Cidara Therapeutics, Inc. Cidara Therapeutics, Inc.

Cidara Therapeutics, Inc.

CDTX

Classifica tra le azioni #3184
Cidara Therapeutics, Inc. is a biotechnology company specializing in the... Cidara Therapeutics, Inc. is a biotechnology company specializing in the creation, advancement, and commercialization of extended-duration anti-infective drugs. Their mission targets the prevention and treatment of infectious diseases and certain cancers within the U.S. Their primary therapeutic candidate, rezafungin acetate, is an innovative echinocandin antifungal designed to combat and avert severe fungal infections such as candidemia and invasive candidiasis, conditions known for their high fatality rates. Additionally, Cidara utilizes its Cloudbreak platform to engineer conjugated therapies aimed at preventing and treating influenza as well as various other viral illnesses, including respiratory syncytial virus (RSV), human immunodeficiency virus (HIV), and SARS-CoV-2, the pathogen behind COVID-19. Originally incorporated in 2012 as K2 Therapeutics, Inc., the company adopted its current name, Cidara Therapeutics, Inc., in July 2014. Its operations are headquartered in San Diego, California.
Prezzo delle azioni
$221.38
Ultima sincronizzazione: 2026-01-08
Capitalizzazione di mercato
$5.61B
Variazione (1 giorno)
0.00%
Variazione (1 anno)
118.07%
Paese
US
Scambia Cidara Therapeutics, Inc. (CDTX)

Categoria

Healthcare
Storico del rendimento da dividendi per Cidara Therapeutics, Inc. (CDTX)
Il rendimento da dividendi (TTM) di Cidara Therapeutics, Inc. (simbolo azionario: CDTX) al 2023-12-31 è: 0.00%
Rendimento medio negli ultimi 5 anni: 0.00%
Storico del rendimento da dividendi per Cidara Therapeutics, Inc. (CDTX) da 2012 a 2026
Rendimento da dividendi alla fine di ogni anno (TTM)
Anno Rendimento da dividendi Cambia
2026 (TTM) 0.00% 0.00%
2024 0.00% 0.00%
2023 0.00% 0.00%
2022 0.00% 0.00%
2021 0.00% 0.00%
2020 0.00% 0.00%
2019 0.00% 0.00%
2018 0.00% 0.00%
2017 0.00% 0.00%
2016 0.00% 0.00%
2015 0.00% 0.00%
2014 0.00% 0.00%
2013 0.00% 0.00%
2012 0.00% 0.00%
Rendimenti da dividendi (TTM) di aziende simili o concorrenti
Azienda Rendimento da dividendi Il paese
0.00%
US
0.00%
US
2.17%
AU
0.00%
CH
0.00%
NL